In this study, we investigated the diagnostic utility of a plasma interleukin panel comprising IL-6, IL-10, IL-8, and IL-1RA to distinguish early-stage NSCLC from healthy individuals and patients with chronic obstructive pulmonary disease (COPD). This evidence concerns the gene IL6 and non-small cell lung carcinoma.